Moscow Launches Sputnik Light Vaccine Study

The Russian Federation's capital city of Moscow, Mayor Sergei Sobyanin, announced on February 18, 2021, an international clinical trial of the Sputnik Light single-dose vaccine had begun.

According to Sobyanin's blog post, a total of 6,000 people will take part in the clinical trials of the Sputnik Light vaccine; 3,000 of them will be from Russia and another 3,000 from the UAE.

"The new vaccine developed by the Gamaleya Institute is meant to eliminate the main disadvantage of the classic Sputnik V vaccine, the presence of two components administered to patients at an interval of several weeks. To get vaccinated with Sputnik Light, a person will need only one visit to an outpatient clinic."

"Immunity will begin to develop a week later, and it will reach the maximum level four weeks after the vaccination," the mayor wrote.